Analysts’ Upgrades for May 13th (BLFS, CSCO, DFH, LILAK, MSCI, NXST, PANL, PHG, RRR, RY)

Analysts’ upgrades for Monday, May 13th:

BioLife Solutions (NASDAQ:BLFS) was upgraded by analysts at Benchmark Co. from a neutral rating to a buy rating. The firm currently has $25.00 target price on the stock.

Cisco Systems (NASDAQ:CSCO) was upgraded by analysts at BNP Paribas from an underperform rating to a neutral rating. BNP Paribas currently has $50.00 target price on the stock.

Dream Finders Homes (NASDAQ:DFH) was upgraded by analysts at Zelman & Associates from a neutral rating to an outperform rating. Zelman & Associates currently has $34.50 target price on the stock.

Liberty Latin America (NASDAQ:LILAK) was upgraded by analysts at Scotiabank from a sector perform rating to a sector outperform rating. They currently have $10.70 target price on the stock, up from their previous target price of $7.70.

MSCI (NYSE:MSCI) was upgraded by analysts at Redburn Atlantic from a neutral rating to a buy rating. Redburn Atlantic currently has $485.00 target price on the stock.

Nexstar Media Group (NASDAQ:NXST) was upgraded by analysts at Wells Fargo & Company from an equal weight rating to an overweight rating. The firm currently has $221.00 target price on the stock, up from their previous target price of $190.00.

Pangaea Logistics Solutions (NASDAQ:PANL) was upgraded by analysts at Alliance Global Partners from a neutral rating to a buy rating. The firm currently has $10.25 target price on the stock.

Koninklijke Philips (NYSE:PHG) was upgraded by analysts at Sanford C. Bernstein from a market perform rating to an outperform rating.

Red Rock Resorts (NASDAQ:RRR) was upgraded by analysts at Bank of America Co. from an underperform rating to a neutral rating. Bank of America Co. currently has $55.00 target price on the stock, down from their previous target price of $57.00.

Royal Bank of Canada (NYSE:RY) (TSE:RY) was upgraded by analysts at Jefferies Financial Group Inc. from a hold rating to a buy rating.

Stellus Capital Investment (NYSE:SCM) was upgraded by analysts at B. Riley from a sell rating to a neutral rating. They currently have $13.25 target price on the stock, up from their previous target price of $12.50.

Receive News & Ratings for BioLife Solutions Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioLife Solutions Inc and related companies with MarketBeat.com's FREE daily email newsletter.